NEWS
You can follow the latest news of MicroViable in this section
Pilar Manrique will present at 9th Microbiome Movement Summit
Pilar Manrique, senior scientist at Microviable Therapeutics will be present at 9th Microbiome Microbiome Movement Summit taking place in Barcelona in January 28-30th 2025! The Summit explored the latest advances in microbiome science, where innovative [...]
Microviable Therapeutics expands leadership team with Chief Financial Officer
Gijón, Spain, September 23rd 2024 – Microviable Therapeutics, a biotech company developing novel biological drugs for infectious diseases and oncology, announced today the appointment of Mehdi Chouikh Skalli as Chief Financial Officer. Mehdi Chouikh has [...]
World Cancer Research Day: Exploring Microbiome-Based Cancer Therapies
On September 24th, we join the global community in recognizing World Cancer Research Day (WCRD)—an international movement dedicated to highlighting the critical role of cancer research in driving breakthroughs for cancer control and treatment. This [...]
David Ríos Covián will participate in the 24th Drug Discovery Innovation Programme
David Ríos Covián, Director of Technology Development at Microviable Therapeutics, will participate in the 24th Drug Discovery Innovation Programme that will take place on 19-20 September in Barcelona. Particularly, David Rios will be present as [...]
Microviable will be attending Drug Discovery Innovation Programme 2024
Microviable is excited to join 24th Drug Discovery Innovation Programme that will take place on 19-20 September in Barcelona. Claudio Hidalgo, CEO at Microviable, will participate as a speaker at the event. Drug Discovery Innovation [...]
Microviable receives best company award at Keiretsu Forum event
Last week we presented Microviable Therapeutics at the online investors chapter of Keiretsu Forum and we got awarded as the best company, by the pool of investors present. Keiretsu Forum is a global investment community [...]